Disruption of XBP1 impairs to PC-LPC cycle and fatty acids desaturation to promote the development of NAFLD via defecting the fatty acid monounsaturated and phospholipid remodeling pathways. Here, XBP1 is linked to metabolic dysfunction-associated steatotic liver disease.